Educational Qualifications

PhD (Tech) in Pharmacology (2022) at Institute of Chemical Technology (ICT), Matunga, Mumbai

Pharmaceutical Chemistry: M. Pharm. (2013) Area of Specialisation:

Pharmacology

Academic responsibilities 

• FYB Pharm Class coordinator: 03 years

Academic Experience

• Total 04 years

Industry Experience

• 02 years

Research
Area Of Research

• Research specialization includes the development, validation, and standardization of rodent and zebrafish experimental models for investigating disease mechanisms and evaluating therapeutic interventions in neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD).
• Assessment of novel pharmacologically active compounds for their therapeutic efficacy in metabolic disorders, particularly diabetes mellitus.
• Experience in the establishment and standardization of in vitro, ex vivo, and in vivo models in rats and zebrafish to support pharmacological, toxicological, and translational research studies.

Publications:

Research: International – 10    National: 01 

• Exploring the therapeutic utility of apocynin in multifactorial neurodegenerative Alzheimer’s disease in a preclinical animal model. Explor Neuroprot Ther.  2025;5:1004128 https://doi.org/10.37349/ent.2025.1004128. 

• Nootropic, Neuroprotective and Anti-oxidant Role of Apocynin in Scopolamine Induced Memory Deficit in a Zebrafih Model. J Pharmacol Pharm Res Volume 4(1): 1-8.  DOI: 10.31038/JPPR.2021414  

• Evaluation of novel and superior formulation CaroTexTM developed by Biofusion Technology." International Journal of Research in Pharmaceutical Sciences 10, no. 3 (2019): 1868-1873. 

• Search for novel anti-fertility agent by monitoring in vitro metabolic 

inhibition, cell motility and cellular interactions of nifedipine analogues. January 2019, Indian Drugs 56(1):32-39. 

• Soy isoflavone Daidzein resembling the vertebrate steroid structure exhibits neuroprotection via mitochondrial biogenesis in rotenone induced Parkinson’s disease in preclinical model. Steroids, p.109703. 

• Investigation of Phytochemicals and Pharmacognostic Features of Feronia Limonia Fruit and Its In Vivo Effects on Oxidative Stress. Int J. of Ayurvedic Med, "Natural to Synthetic: The Convergence of Traditional Medicine to Modern Medicine” Supplement  2025, Vol. 16 No. S2 (2025): Natural to Synthetic: The Convergence of Traditional Medicine to Modern Medicine 2025. 

• "Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson’s disease–emphasizing the role of mitochondrial biogenesis." Brain Research Bulletin (2020). 

• Neuroprotective Effect of Coumarin Nasal Formulation: Kindling Model Assessment of Epilepsy. Frontiers in Pharmacology, 2018; 9: 992.  

• ‘In- vitro pancreatic lipase inhibition potential of commonly used Indian spices’. IOSR Journal Of Pharmacy, 2016, 6(10):10-13.  

• Standardization of type 1 and type 2 diabetic nephropathy models in rats: Assessment and characterization of metabolic features and renal injury. Journal of Pharmacy And Bioallied Sciences. 2020 Jul 1;12(3):295. 

• Ethyl ferulate, a lipophilic pheny propanoid, prevents diabetes associated renal injury in rats by amelioration of hyperglycemia induced oxidative stress via activation of nuclear factor erythroid 2-related factor 2. Journal of Food Biochemistry. 2020 Jul 1;12(3):295.

Industry Projects

• Compositions of Ivermectin and Theophylline for treating acute lung injury 
• Evaluation of novel and superior formulation CaroTexTM developed by Biofusion Technology

Grants Received:

• Received D Y Patil Deemed to be University Research Excellence grant of INR. 1 lakh, entitled ‘Mechanistic evaluation of marigold flower extract for its diabetes induced anti-cataract potential’ (Award letter number SN.RAC2023-24/REXL – 01)

Awards:

• Won Best Oral Presentation for topic entitled “Apocynin: A potential moiety that can treat the underlying AD pathology and symptoms!” at the 25th Annual National Convention of APTICON 2022 from 02nd to 04th September 2022 at JSS College of Pharmacy, JSSAHER, Mysuru. 
• Awarded USISTEF fellowship for project entitled “Ivermectin for Treatment of COVID-19”, under INDO-US, United States-India Science & Technology Endowment Fund: COVID-19 Ignition Grants/Application # USISTEF/COVID-I/136/2020. 
• Granted Indian Patent entitled “Compositions of ivermectin and theophylline for treating acute lung injury” (Patent number: 431180)